熱門詞: 進(jìn)口電動(dòng)溫度調(diào)節(jié)閥結(jié)構(gòu)圖|進(jìn)口電動(dòng)溫度調(diào)節(jié)閥數(shù)據(jù)表進(jìn)口電動(dòng)高溫調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)高溫法蘭調(diào)節(jié)閥進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥
荷蘭Sanquin
Sanquin(荷蘭)成立于1998年,由荷蘭血庫(kù)和荷蘭紅十字輸血服務(wù)部中心實(shí)驗(yàn)室(CLB)合并成立。Sanquin負(fù)責(zé)非營(yíng)利性的供應(yīng)血液,關(guān)注輸血相關(guān)進(jìn)展使其滿足對(duì)質(zhì)量、安全性和高效性的最高的要求。Sanquin提供了各種產(chǎn)品和服務(wù),并進(jìn)行了科研調(diào)查,安排了預(yù)防教育,指導(dǎo)、在職期間的培訓(xùn)和課程進(jìn)修。
根據(jù)血液供應(yīng)法,Sanquin被批準(zhǔn)為荷蘭管理血液和血制品的唯一機(jī)構(gòu)。Sanquin是非營(yíng)利性機(jī)構(gòu)。在荷蘭,Sanquin有大約2800名員工。
Sanquin堅(jiān)持不懈的進(jìn)行探索研究來(lái)開(kāi)發(fā)革新的血制品??紤]到臨床實(shí)驗(yàn)人員由于年齡、妊娠、疾病及其他變動(dòng)等因素,公司安排了大約有10%的固定的臨床實(shí)驗(yàn)人員來(lái)替換。穩(wěn)定的質(zhì)量保證和革新的發(fā)展策略強(qiáng)手聯(lián)合使Sanquin公司永遠(yuǎn)立于國(guó)際領(lǐng)先水平。
公司產(chǎn)品主要有:
人IgG 亞型分類(Human IgG subclasses) | 散射比濁法( Nephelometry) |
免疫擴(kuò)散沉淀技術(shù)(Immunodiffusion precipitation techniques) | |
酶標(biāo)技術(shù)(ELISA techniques) | |
單克隆抗體(Monoclonal antibodies) | |
細(xì)胞因子,T-淋巴細(xì)胞可釋放顆粒酶及相關(guān)蛋白( Cytokines, granzymes and related proteins) | ELISA產(chǎn)品(ELISA products) |
ELISPOT產(chǎn)品(ELISPOT products) | |
PeliKine TM人細(xì)胞因子酶標(biāo)試劑盒(PeliKineTM human cytokine ELISA kits) | |
PeliKineTM人細(xì)胞因子與T-淋巴細(xì)胞可釋放顆粒 酶酶標(biāo)試劑盒(PeliKineTM-compact human cytokine and granzyme ELISA kits) | |
Pelipair試劑系列,1824測(cè)定(19塊板)(Pelipair eagent sets, 1824 tests (19 plates) PeliSPOTTM ElISPOT) 試劑盒與抗體對(duì)A.EL.VIS ELISPOT 分析( PeliSPORTTM ELISPOT kits and antibody pair, A.EL.VIS ELISPOT analysers) | |
流色細(xì)胞術(shù)試劑(Reagent for flow cytometry) | PeliMers, 組織相容性復(fù)合物 (PeliMers, MHC-multimers) |
PeliCluster 單克隆抗體(PeliCluster monoclonal antibodies) | |
非clustered抗體 ,T-淋巴細(xì)胞可釋放顆粒酶抗體(Non clustered antibodies, granzyme antibodies) | |
PeliDuo 單克隆抗體系列(PeliDuo monoclonal antibody sets) | |
PeliTrio單克隆抗體系列(PeliTrio monoclonal antibody sets) | |
PeliCluster細(xì)胞刺激抗體(PeliCluster cell-stimulating antibodies) | |
其它試劑與試劑盒(Other reagents and kits) | 甘露糖結(jié)合血凝素酶標(biāo)試劑盒(Mannose binding lectin ELISA kit) |
抗牛海綿狀腦病單克隆抗體(克隆1E4)(Anti-prion monoclonal antibody (clone 1 E 4)) | |
抗血漿蛋白單克隆抗體(Monoclonal antibodies to serum proteins) | |
抗血漿蛋白多克隆抗體, 沉淀技術(shù)(Polyclonal antibodies to serum proteins, precipitation techniques) | |
抗血漿蛋白多克隆抗體,散射比濁法技術(shù)(Polyclonal antibodies to serum proteins, nephelometric techniques) | |
血漿蛋白標(biāo)記抗體(Labelled antibodies to serum proteins) | |
IgM 風(fēng)濕因子酶標(biāo)試劑盒(IgM rheumatoid factor ELISA kit) | |
正常動(dòng)物血清(Normal animal sera) |
Sanquin was established in 1998 through a merger between the Dutch blood banks and the Central Laboratory of the Netherlands Red Cross Blood Transfusion Service (CLB). The Foundation is responsible for blood supply on a not-for-profit basis and advances transfusion medicine as such that it fulfils the highest demands for quality, safety and efficiency. Sanquin delivers products and services, conducts scientific investigations and provides education, instruction, in-service training and refresher courses.
On the basis of the Blood Supply Act, Sanquin is the only organisation in the Netherlands authorised to manage our need for blood and blood products. It is also a not-for-profit organisation and thus has no profit motive. Sanquin employs approximately 2,800 workers all across the Netherlands.
The Sanquin organisation is constantly conducting research and developing new and improved blood products. There is also a constant search to replace the roughly 10% of the donors who become unavailable due to age, pregnancy, illness or relocation.
At Sanquin, consistent quality and development through improvements therefore go hand in hand.